Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Botulinum Neurotoxins and Nervous System : Future Challenges for Novel Indications
| Botulinum Neurotoxins and Nervous System : Future Challenges for Novel Indications |
| Autore | Luvisetto Siro |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (368 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
abobotulinumtoxinA
allodynia antipruritic appropriate treatment astroglia basal ganglia biological effect BoNT/A botulinum antitoxin botulinum neurotoxin botulinum neurotoxin serotype A botulinum neurotoxin serotype a heavy chain (BoNT/A HC) botulinum neurotoxin-A botulinum neurotoxins botulinum toxin Botulinum toxin botulinum toxin A botulinum toxin therapy botulinum toxin type A BTX central neuropathic pain cerebral palsy chloroquine chronic pelvic pain clinical clinical decision support clinical trial Clostridium tetani complex regional pain syndrome compound 48/80 delivery dental occlusion dermatology diagnostic guidance drooling dystonic tremor early use eccrine glands electrical activity electrical stimulation electromyography epilepsy essential tremor experimental food safety formulation glia growth associated protein 43 (GAP-43) hand hand tremor heavy chain human immunohistochemistry incobotulinumtoxin A interleukins interneurons interspecies differences in motor behavior itch joint biomechanics kinematics lateral pterygoid muscle limb tremors lumbar sympathetic ganglion block mast cells masticatory system maxillofacial bone medication overuse headache microglia mouse mouse test movement disorders muscle selection n/a nerve regeneration neural regeneration neuronal processes neurotransmission blockade neurotransmitter new indications novel indication onabotulinumtoxin A ONTIME orthognathic surgery overactive detrusor pain Parkinson's disease post-stroke post-stroke shoulder pain prion disease prophylactic treatment pruritus rat refractory chronic migraine rehabilitation salivary glands Schwann cells sciatic static index sialorrhoea Snap-23 SNAP-25 SNARE spastic paresis spasticity spinal cord spinal cord injury spinal cord injury (SCI) stroke management superior cervical ganglion 10 (SCG10) swallowing synaptic transmission temporomandibular joint dislocation tension headache Therapeutic Index TLR2 TLR4 treatment tremor upper limb biomechanics upper limb spasticity urodynamics vaginism VAMP various cell types walking track analysis weight bearing XEOMIN® |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Botulinum Neurotoxins and Nervous System |
| Record Nr. | UNINA-9910557109003321 |
Luvisetto Siro
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Transmucosal Absorption Enhancers in the Drug Delivery Field
| Transmucosal Absorption Enhancers in the Drug Delivery Field |
| Autore | Maher Sam |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (406 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
absorption enhancement
absorption enhancer absorption enhancers absorption modifying excipients Aloe vera amino acid amphiphilic polymers and liposome antiepileptic drug antimicrobial peptide biocompatibility studies bioenhancer block copolymers brush border Caco-2 Caco-2 cells cationic functionalization cell-penetrating peptide cell-penetrating peptide (CPP) cervicovaginal tumors chitosan chitosan derivatives claudin clinical trial CNS disorders combined microsphere compound 48/80 confocal laser scanning microscopy cornea curcumin cyclodextrin cytochrome P450 drug absorption enhancer drug administration drug delivery efflux enterocyte epithelial permeability epithelial transport epithelium F-actin FITC-dextran formulation gel gemini surfactant GLP-1 hydrophobization imatinib in situ hydrogel in vivo studies insulin intestinal absorption intestinal delivery intestinal epithelial cells intestinal permeation enhancers KLAL man mast cell activator metabolism mucoadhesion mucoadhesiveness N-dodecyl-?-D-maltoside (DDM) nanocapsules nanocrystals nanomedicine nanoparticle nanoparticles nasal nasal delivery nasal formulation nasal permeability nasal vaccination nose to brain delivery nose to brain transport nose-to-brain ocular conditions ocular delivery ocular drug delivery ophthalmology oral delivery oral macromolecule delivery oral peptides osteoporosis P-glycoprotein penetration enhancer penetration enhancers permeability permeation enhancer permeation enhancers pharmacokinetic interaction pharmacokinetics PN159 polymeric micelles poorly absorbed drug preclinical PTH 1-34 pulmonary quaternization safety salcaprozate sodium sheep simulated intestinal fluid simvastatin small intestine sodium caprate sodium cholate (NaC) sugar-based surfactants teriparatide thermogel system tight junction tight junction modulator tight junctions transepithelial electrical resistance transferrin transmucosal drug delivery transmucosal permeation tryptophan vaccine adjuvant vaginal delivery whole leaf |
| ISBN | 3-03921-849-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910372785603321 |
|
Maher Sam
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||